<p>Cervical Cancer: Emerging Immune Landscape and Treatment</p>
Luopei Guo, Keqin Hua
Abstract
Immune cells are essential for defending the body's balance and have increasingly been implicated in controlling tumor growth. In cervical cancer (CC), the immune landscape is extensively connected with human papillomavirus (HPV) status. Recent insights from studies have revealed that as a result of infection with HPV, immune cell populations such as lymphocytes or monocytes change during carcinogenesis. Immune therapy, in particular checkpoint inhibitors, those targeting PD-1 or PD-L1, has shown promising efficacy. This article reviews the immune landscape and immunotherapy of CC.
Topics & Concepts
Immune systemCervical cancerImmunotherapyMedicineImmunologyCarcinogenesisCancerImmune checkpointHuman papillomavirusCancer researchInternal medicineCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesImmune Cell Function and Interaction